相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detecting and Treating Cancer with Nanotechnology
Keith B. Hartman et al.
Molecular Diagnosis & Therapy (2012)
Polymer-drug conjugates: current status and future trends
Francesca Greco et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes
Joanne L. Blum et al.
CLINICAL BREAST CANCER (2007)
Characterization of nanoparticles for therapeutics
Jennifer B. Hall et al.
NANOMEDICINE (2007)
Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin
Jing Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin
J. J. Yu et al.
JOURNAL OF DRUG TARGETING (2007)
Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation
Tania Betancourt et al.
NANOMEDICINE (2007)
Nanomedicines and nanotoxicology: some physiological principles
M. C. Garnett et al.
OCCUPATIONAL MEDICINE-OXFORD (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Optimizing efficacy of amphotericin B through nanomodification
Suresh P. Vyas et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f: Potent antitumor activities in various murine tumor models
E Kumazawa et al.
CANCER SCIENCE (2004)
Drug delivery and transport to solid tumors
SH Jang et al.
PHARMACEUTICAL RESEARCH (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting
K Greish et al.
CLINICAL PHARMACOKINETICS (2003)
Nanoparticles in cancer therapy and diagnosis
I Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Novel effects with polyethylene glycol modified pharmaceuticals
SL Yowell et al.
CANCER TREATMENT REVIEWS (2002)
Clinical uses of pegylated pharmaceuticals in oncology
J Crawford
CANCER TREATMENT REVIEWS (2002)
Synthesis and biological properties of antitumor-active conjugates of ADR with dextran
JA Guu et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2002)
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier
S Mitra et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Chitosan nanoparticles as delivery systems for doxorubicin
KA Janes et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Nanoparticulate systems for brain delivery of drugs
J Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2001)
Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro
CE Soma et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system
U Gaur et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran size
W Lam et al.
ANTI-CANCER DRUGS (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
